Xencor: 4Q Earnings Snapshot

Associated Press
Updated ·1 min read

MONROVIA, Calif. (AP) _ Xencor Inc. (XNCR) on Monday reported a loss of $26.9 million in its fourth quarter.

On a per-share basis, the Monrovia, California-based company said it had a loss of 47 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.

The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $3.5 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $6.7 million.

For the year, the company reported net income of $29 million, or 46 cents per share, swinging to a profit in the period. Revenue was reported as $156.7 million.

Xencor shares have decreased 3% since the beginning of the year. In the final minutes of trading on Monday, shares hit $33.32, an increase of slightly more than 5% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR